ATE324883T1 - PHARMACEUTICAL COMPOSITION CONTAINING LUMIRACOXIB - Google Patents

PHARMACEUTICAL COMPOSITION CONTAINING LUMIRACOXIB

Info

Publication number: ATE324883T1
Authority: AT; Austria
Prior art keywords: lumiracoxib; pharmaceutical composition; composition containing; pharmaceutical; containing lumiracoxib
Prior art date: 2001-08-31

Application number

AT02767455T

Other languages

German (de)

Inventor

Anees Abdulquadar Karnachi

Simon David Bateman

Original Assignee

Novartis Erfind Verwalt Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-31

Filing date

2002-08-30

Publication date

2006-06-15

2002-08-30 Application filed by Novartis Erfind Verwalt Gmbh filed Critical Novartis Erfind Verwalt Gmbh

2006-06-15 Application granted granted Critical

2006-06-15 Publication of ATE324883T1 publication Critical patent/ATE324883T1/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT02767455T 2001-08-31 2002-08-30 PHARMACEUTICAL COMPOSITION CONTAINING LUMIRACOXIB ATE324883T1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US31638901P	2001-08-31	2001-08-31

Publications (1)

Publication Number	Publication Date
ATE324883T1 true ATE324883T1 (en)	2006-06-15

Family

ID=23228840

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02767455T ATE324883T1 (en)	2001-08-31	2002-08-30	PHARMACEUTICAL COMPOSITION CONTAINING LUMIRACOXIB

Country Status (30)

Country	Link
US (2)	US20030114527A1 (en)
EP (1)	EP1425005B1 (en)
JP (1)	JP4636796B2 (en)
KR (1)	KR100895551B1 (en)
CN (1)	CN100406008C (en)
AR (1)	AR036312A1 (en)
AT (1)	ATE324883T1 (en)
AU (1)	AU2002331094B2 (en)
BR (1)	BR0212155A (en)
CA (1)	CA2456604C (en)
CO (1)	CO5560554A2 (en)
CY (1)	CY1106137T1 (en)
DE (1)	DE60211183T2 (en)
DK (1)	DK1425005T3 (en)
EC (1)	ECSP044986A (en)
ES (1)	ES2263813T3 (en)
HK (1)	HK1087336A1 (en)
HU (1)	HUP0401429A2 (en)
IL (1)	IL160375A0 (en)
MX (1)	MXPA04001933A (en)
MY (1)	MY137516A (en)
NO (1)	NO20040860L (en)
NZ (1)	NZ531342A (en)
PE (1)	PE20030323A1 (en)
PL (1)	PL367464A1 (en)
PT (1)	PT1425005E (en)
RU (1)	RU2329801C2 (en)
SI (1)	SI1425005T1 (en)
WO (1)	WO2003020261A1 (en)
ZA (1)	ZA200400877B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20020351A1 (en) *	2000-09-11	2002-06-14	Novartis Ag	PHARMACEUTICAL COMPOSITIONS INCLUDING 5-METHYL-2- (2'-CHLORO-6'-FLUOROANILINE) PHENYLACETIC ACID AS INHIBITOR OF CYCLOOXYGENASE-2
GB0201520D0 (en) *	2002-01-23	2002-03-13	Novartis Ag	Pharmaceutical uses
PL370907A1 (en) *	2002-03-07	2005-05-30	Novartis Ag	Pharmaceutical compositions
MX2011001341A (en)	2008-08-19	2011-03-29	Xenoport Inc	Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use.
US20140093563A1 (en) *	2011-06-13	2014-04-03	Ranbaxy Laboratories Limited	Febuxostat compositions
US10952968B2 (en)	2012-05-14	2021-03-23	Shionogi & Co., Ltd.	Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives
US10945984B2 (en)	2012-08-22	2021-03-16	Arbor Pharmaceuticals, Llc	Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
AU2013305684B2 (en)	2012-08-22	2016-11-24	Xenoport, Inc.	Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
EA018867B1 (en) *	2012-11-01	2013-11-29	Лаборатория Тютор С.А.С.И.Ф.И.А.	Method of producing pharmaceutical composition and product therefrom
WO2014160633A1 (en)	2013-03-24	2014-10-02	Xenoport, Inc.	Pharmaceutical compositions of dimethyl fumarate
WO2014197860A1 (en)	2013-06-07	2014-12-11	Xenoport, Inc.	Method of making monomethyl fumarate
WO2014205392A1 (en)	2013-06-21	2014-12-24	Xenoport, Inc.	Cocrystals of dimethyl fumarate
JP2016534133A (en)	2013-09-06	2016-11-04	ゼノポート，インコーポレイティド	Crystal form of (N, N-diethylcarbamoyl) methyl methyl (2E) but-2-ene-1,4-dioate, its synthesis and use
KR20160107254A (en) *	2014-01-10	2016-09-13	존슨 앤드 존슨 컨수머 인코포레이티드	Process for making tablet using radiofrequency and lossy coated particles
US9999672B2 (en)	2014-03-24	2018-06-19	Xenoport, Inc.	Pharmaceutical compositions of fumaric acid esters
EP3162362A1 (en) *	2015-10-30	2017-05-03	Dr. Falk Pharma Gmbh	Optimized high-dose tablet of mesalazine
US10493026B2 (en)	2017-03-20	2019-12-03	Johnson & Johnson Consumer Inc.	Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2163111C (en) *	1993-06-08	2010-10-26	Peter Heinrich Stahl	Process for the preparation of an oral solid dosage form containing diclofenac
JPH11512754A (en) *	1996-05-17	1999-11-02	メルクエンドカンパニーインコーポレーテッド	Composition for once-daily treatment of cyclooxygenase-2-mediated disease
CO4960662A1 (en) *	1997-08-28	2000-09-25	Novartis Ag	CERTAIN 5-ALKYL-2-ARYLAMINOPHENYLACETIC ACIDS AND THEIR DERIVATIVES
SA99191255B1 (en) *	1998-11-30	2006-11-25	جي دي سيرل اند كو	celecoxib compounds
PE20020351A1 (en) *	2000-09-11	2002-06-14	Novartis Ag	PHARMACEUTICAL COMPOSITIONS INCLUDING 5-METHYL-2- (2'-CHLORO-6'-FLUOROANILINE) PHENYLACETIC ACID AS INHIBITOR OF CYCLOOXYGENASE-2

2002
- 2002-08-29 US US10/231,438 patent/US20030114527A1/en not_active Abandoned
- 2002-08-29 AR ARP020103257A patent/AR036312A1/en unknown
- 2002-08-29 PE PE2002000832A patent/PE20030323A1/en not_active Application Discontinuation
- 2002-08-30 AU AU2002331094A patent/AU2002331094B2/en not_active Ceased
- 2002-08-30 EP EP02767455A patent/EP1425005B1/en not_active Expired - Lifetime
- 2002-08-30 JP JP2003524569A patent/JP4636796B2/en not_active Expired - Fee Related
- 2002-08-30 MY MYPI20023252A patent/MY137516A/en unknown
- 2002-08-30 HU HU0401429A patent/HUP0401429A2/en unknown
- 2002-08-30 CN CNB02816895XA patent/CN100406008C/en not_active Expired - Fee Related
- 2002-08-30 WO PCT/EP2002/009701 patent/WO2003020261A1/en active IP Right Grant
- 2002-08-30 PL PL02367464A patent/PL367464A1/en not_active Application Discontinuation
- 2002-08-30 IL IL16037502A patent/IL160375A0/en unknown
- 2002-08-30 ES ES02767455T patent/ES2263813T3/en not_active Expired - Lifetime
- 2002-08-30 CA CA2456604A patent/CA2456604C/en not_active Expired - Fee Related
- 2002-08-30 BR BR0212155-7A patent/BR0212155A/en not_active IP Right Cessation
- 2002-08-30 KR KR1020047002925A patent/KR100895551B1/en not_active IP Right Cessation
- 2002-08-30 DE DE60211183T patent/DE60211183T2/en not_active Expired - Lifetime
- 2002-08-30 DK DK02767455T patent/DK1425005T3/en active
- 2002-08-30 MX MXPA04001933A patent/MXPA04001933A/en active IP Right Grant
- 2002-08-30 PT PT02767455T patent/PT1425005E/en unknown
- 2002-08-30 AT AT02767455T patent/ATE324883T1/en active
- 2002-08-30 RU RU2004109920/15A patent/RU2329801C2/en not_active IP Right Cessation
- 2002-08-30 NZ NZ531342A patent/NZ531342A/en not_active IP Right Cessation
- 2002-08-30 SI SI200230367T patent/SI1425005T1/en unknown
2004
- 2004-02-03 ZA ZA200400877A patent/ZA200400877B/en unknown
- 2004-02-25 EC EC2004004986A patent/ECSP044986A/en unknown
- 2004-02-25 CO CO04016658A patent/CO5560554A2/en not_active Application Discontinuation
- 2004-02-26 NO NO20040860A patent/NO20040860L/en not_active Application Discontinuation
2006
- 2006-07-10 HK HK06107694.8A patent/HK1087336A1/en not_active IP Right Cessation
- 2006-08-03 CY CY20061101093T patent/CY1106137T1/en unknown
2007
- 2007-05-17 US US11/804,284 patent/US20070231382A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2005520785A (en)	2005-07-14
DK1425005T3 (en)	2006-09-04
BR0212155A (en)	2004-07-13
PT1425005E (en)	2006-09-29
CO5560554A2 (en)	2005-09-30
PL367464A1 (en)	2005-02-21
CN100406008C (en)	2008-07-30
ZA200400877B (en)	2004-11-01
EP1425005A1 (en)	2004-06-09
EP1425005B1 (en)	2006-05-03
AR036312A1 (en)	2004-08-25
DE60211183D1 (en)	2006-06-08
HUP0401429A2 (en)	2004-11-29
DE60211183T2 (en)	2007-02-01
HK1087336A1 (en)	2006-10-13
AU2002331094B2 (en)	2006-08-31
MXPA04001933A (en)	2004-06-15
KR100895551B1 (en)	2009-04-29
IL160375A0 (en)	2004-07-25
JP4636796B2 (en)	2011-02-23
NO20040860L (en)	2004-04-22
CY1106137T1 (en)	2011-06-08
ECSP044986A (en)	2004-04-28
PE20030323A1 (en)	2003-05-12
KR20040031019A (en)	2004-04-09
US20030114527A1 (en)	2003-06-19
CA2456604C (en)	2011-02-08
US20070231382A1 (en)	2007-10-04
ES2263813T3 (en)	2006-12-16
CA2456604A1 (en)	2003-03-13
MY137516A (en)	2009-02-27
WO2003020261A1 (en)	2003-03-13
RU2329801C2 (en)	2008-07-27
NZ531342A (en)	2005-09-30
CN1728993A (en)	2006-02-01
RU2004109920A (en)	2005-04-20
SI1425005T1 (en)	2006-12-31

Legal Events

Date

Code

Title

Description

2007-01-15

EEIH

Change in the person of patent owner

2007-02-15

UEP

Publication of translation of european patent specification

Ref document number: 1425005

Country of ref document: EP

Publication	Publication Date	Title
FI20011478A0 (en)	2001-07-05	Pharmaceutical composition
DE60127002D1 (en)	2007-04-12	PHARMACEUTICAL COMPOSITION
AT7729U3 (en)	2006-01-15	PHARMACEUTICAL COMPOSITIONS CONTAINING AMLODIPINMALEAT
DE60206889D1 (en)	2005-12-01	PHARMACEUTICAL FORMULATION CONTAINING BICALUTAMIDE
NO20033556L (en)	2003-10-09	Pharmaceutical Formulations
ATE334656T1 (en)	2006-08-15	LIQUID PHARMACEUTICAL COMPOSITION
NO20033384L (en)	2003-09-25	Pharmaceutical Formulation
ATE320807T1 (en)	2006-04-15	PHARMACEUTICAL COMPOSITIONS CONTAINING TEGASEROD
EE05020B1 (en)	2008-06-16	The pharmaceutical composition of G1buride
EE200300589A (en)	2004-02-16	Pharmaceutical compositions
NO20035627D0 (en)	2003-12-15	Pharmaceutical formulation
ATE324883T1 (en)	2006-06-15	PHARMACEUTICAL COMPOSITION CONTAINING LUMIRACOXIB
ATE477814T1 (en)	2010-09-15	PHARMACEUTICAL COMPOSITION CONTAINING STABLE FACTOR-VIII
FI20022128A (en)	2003-06-06	Pharmaceutical composition
ATE350016T1 (en)	2007-01-15	PHARMACEUTICAL COMPOSITION CONTAINING BICALUTAMID
DE60129238D1 (en)	2007-08-16	PHARMACEUTICAL COMPOSITION
PT1227817E (en)	2004-11-30	AQUOSA PHARMACEUTICAL COMPOSITION CYCLOSONIDE CONTAINING
DE10291905D2 (en)	2004-05-27	Pharmaceutical composition
ATE350029T1 (en)	2007-01-15	PHARMACEUTICAL COMPOSITION CONTAINING GAMMA-BUTYROBETAIN
NO20033073L (en)	2003-07-04	Pharmaceutical composition containing citalopram
DE10107261B4 (en)	2005-03-10	Pharmaceutical composition
FI5468U1 (en)	2002-07-30	Pharmaceutical composition
NO20041236L (en)	2004-03-24	Pharmaceutical Formulation
SE0100847D0 (en)	2001-03-09	Novel pharmaceutical composition
SE0101171D0 (en)	2001-04-02	Pharmaceutical formulation